KBC Group’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120K | Sell |
10,667
-5,609
| -34% | -$63.1K | ﹤0.01% | 1095 |
|
|
2025
Q1 | $164K | Buy |
16,276
+402
| +3% | +$4.05K | ﹤0.01% | 1178 |
|
|
2024
Q4 | $188K | Buy |
15,874
+5,839
| +58% | +$69.2K | ﹤0.01% | 1165 |
|
|
2024
Q3 | $116K | Hold |
10,035
| – | – | ﹤0.01% | 1193 |
|
|
2024
Q2 | $106K | Buy |
10,035
+3,268
| +48% | +$34.5K | ﹤0.01% | 1132 |
|
|
2024
Q1 | $71K | Hold |
6,767
| – | – | ﹤0.01% | 1328 |
|
|
2023
Q4 | $76K | Sell |
6,767
-774
| -10% | -$8.69K | ﹤0.01% | 1238 |
|
|
2023
Q3 | $88K | Buy |
+7,541
| New | +$88K | ﹤0.01% | 1068 |
|